analyzeportfolio
NYSE · Healthcare

Concentra Group Holdings Parent, Inc. (CON)

As-reported financials and SEC filings for Concentra Group Holdings Parent, Inc. The latest annual period is FY2025. The latest reported quarter is Q2 FY2026. Financial statements come straight from the company’s EDGAR filings; valuation figures such as P/E and market cap use market data.

About Concentra Group Holdings Parent, Inc.

Concentra Group Holdings Parent, Inc. provides services primarily in the healthcare sector. The company generates revenue through cost of services and general administrative activities, serving a broad customer base. It manages assets including property, equipment, and intangible assets, and maintains liabilities such as long-term debt and operating lease obligations.

Snapshot

Revenue
$2.16B
Revenue growth (YoY)
13.9%
Net income
$166.4M
Diluted EPS
$1.30
Gross margin
Operating margin
15.4%
Net margin
7.7%
FCF margin
9.1%
ROE
41.5%
net income / fiscal-year-end equity
P/E
22.4×
trailing when available, otherwise FY EPS
Market cap
$4.42B
Long-term debt / equity
3.90×
non-current term debt only

Fundamentals are from SEC filings for FY2025, the latest annual period (ended December 31, 2025). P/E and market cap are derived from stored market prices, last retrieved on a rolling basis and typically within the past week.

What changed at Concentra Group Holdings Parent

  • Revenue grew 13.9% to $2.2B in FY2025, faster than the 3.4% the year before.
  • Operating margin is 15.4% in FY2025, +0.4 pp against 15.0% in FY2022.
  • Most recent quarter Q2 FY2026: revenue $606M, up 10.0% from Q2 FY2025.
  • Free cash flow was $197M in FY2025, 9.1% of revenue.
  • Net income fell 0.1% to $166M in FY2025.

Computed from the as-reported figures in the statements below. A change we cannot state from filed figures is left out rather than estimated.

Peer comparison

Where Concentra Group Holdings Parent’s fundamentals sit among the 558 Healthcare companies. Each figure is ranked only against peers that report it, from lowest (left) to highest (right).

Operating margin15.4%
80th percentile of 399
Net margin7.7%
69th percentile of 418
FCF margin9.1%
65th percentile of 372
Revenue growth (YoY)+13.9%
58th percentile of 538
ROE41.5%
95th percentile of 473
P/E22.4×
46th percentile of 201
Long-term debt / equity3.90×
94th percentile of 243
Short interest1.88d
18th percentile of 557

Concentra Group Holdings Parent’s return on equity of 41.5% ranks in the 95th percentile of the 473 Healthcare companies reporting it. Concentra Group Holdings Parent’s long-term debt to equity of 3.90 ranks in the 94th percentile of the 243 Healthcare companies reporting it.

No reported insider purchases (code P) in the last 90 days; 2 insider sales totaling $8.1M. For context, about 15% of companies in the universe saw any reported insider purchase (code P) in the same window. Browse insider activity →

Percentiles describe where a figure sits among sector peers reporting it (100th = highest). They are position within a peer group, not a rating, and not investment advice. Short interest ranking uses days to cover from FINRA Consolidated Short Interest data; FINRA is the owner and source of that data, included at no additional charge.

Institutional ownership

Held by 1 of the superinvestors we track (plus 5 quant / multi-strat books), based on each investor’s most recent 13F; periods vary by investor (newest: Q2 2026).

Conviction investors
1
+5 quant / multi-strat
Initiated / added
5
1 new, 4 added
Reduced / exited
3
1 trimmed, 2 exited
Combined position
$56.1M
reported long value
InvestorAs ofPosition valueSharesChange
Millennium ManagementquantQ2 2026$22.3M750.0KAdded
First Eagle Investment ManagementQ2 2026$19.3M648.1KAdded
D. E. ShawquantQ2 2026$4.6M154.3KAdded
Citadel AdvisorsquantQ2 2026$4.5M151.0KReduced
Point72 Asset ManagementquantQ2 2026$3.1M103.8KNew
AQR Capital ManagementquantQ2 2026$2.3M79.0KAdded

No longer held by: Gotham Asset Management (as of Q2 2026), Maverick Capital (as of Q2 2026)

From quarterly Form 13F filings, which can be up to 45 days delayed. Long US-listed positions only: excludes short positions, options, cash, bonds, and non-US holdings, so this is not a manager’s complete portfolio. Counts are of the investors we track, not all institutions. Not investment advice.

Recent insider activity

Non-derivative buys and sells (codes P/S) reported by officers, directors and 10% owners on SEC Form 4.

Buys (90d)
0
code P
Bought (90d)
code P value
Sells (90d)
2
$8.1M
Reported activity
Net selling
by $ value, 90d
Trade dateInsiderTypeSharesPriceValue
2026-08-03
filed 2026-08-05
ORTENZIO ROBERT ADirectorSell130.0K$31.84$4.1M
2026-07-01
filed 2026-07-06
ORTENZIO ROBERT ADirectorSell130.0K$30.50$4.0M
2026-06-01
filed 2026-06-02
ORTENZIO ROBERT ADirectorSell130.0K$25.00$3.3M
2026-05-08
filed 2026-05-11
ORTENZIO ROBERT ADirectorSell130.0K$25.00$3.3M

Reported non-derivative purchases and sales (codes P/S) — which may be open-market or private; excludes option exercises, grants, and shares withheld for taxes. Dates shown are the trade date; a Form 4 can be filed days to years later. A sale can be routine (e.g. a pre-set 10b5-1 plan), so read individual transactions in context. From SEC Form 4. Not investment advice.

Short interest

Total shares sold short as of each twice-monthly FINRA settlement. Rising short interest means more investors are positioned against the stock; days to cover estimates how many trading days of average volume that position represents.

Shares short
2.2M
settled 2026-08-14
Change vs prior
-29.2%
vs previous settlement
Days to cover
1.88
at avg daily volume
Avg daily volume
1.2M
FINRA reported
SettlementShares shortChangeDays to cover
2026-08-142.2M-29.2%1.88
2026-07-313.1M-7.4%3.95
2026-07-153.4M+18.6%3.22
2026-06-302.9M+7.6%2.53
2026-06-152.7M-0.5%2.92
2026-05-292.7M+20.3%3.63
2026-05-152.2M-23.1%1.91
2026-04-302.9M+18.8%5.37

Source: FINRA Consolidated Short Interest. FINRA is the owner and source of the FINRA-supplied data, which is included at no additional charge for your own personal or professional use; republishing or redistributing it is not permitted. Settlement dates are shown; FINRA publishes each settlement about nine business days later, so the latest figure can be two to four weeks old. Not presented as a percentage of float. No FINRA endorsement of this product is implied. Not investment advice.

Income statement (as reported)

 FY2025FY2024FY2023FY2022
Revenue$2.16B$1.90B$1.84B$1.72B
Gross profit
Operating income$334.0M$304.8M$287.6M$258.5M
Net income$166.4M$166.5M$179.9M$166.7M
Diluted EPS$1.30$1.46$1.73$1.60

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.

Balance sheet (as reported)

 FY2025FY2024FY2023FY2022
Cash and equivalents$79.9M$183.3M$31.4M$37.7M
Current assets$383.1M$437.2M$294.4M
Total assets$2.86B$2.52B$2.33B$2.30B
Current liabilities$337.2M$307.2M$274.6M
Long-term debt$1.56B$1.47B$3.3M
Total liabilities$2.44B$2.22B$1.16B$1.32B
Total equity$401.0M$280.7M$1.16B$979.3M

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.

Cash flow (as reported)

 FY2025FY2024FY2023FY2022
Operating cash flow$279.4M$274.7M$234.3M$274.3M
Capital expenditure$82.3M$64.3M$65.0M$46.0M
Free cash flow$197.1M$210.3M$169.4M$228.4M

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.

Quarterly trend (as reported)

QuarterRevenueRevenue YoYNet incomeDiluted EPS
Q2 FY2026$606.0M10.0%$65.3M$0.51
Q1 FY2026$569.6M13.7%$50.5M$0.39
Q4 FY2025$539.1M15.9%$34.7M$0.27
Q3 FY2025$572.8M17.0%$48.3M$0.38
Q2 FY2025$550.8M15.2%$44.6M$0.35
Q1 FY2025$500.8M7.1%$38.9M$0.30
Q4 FY2024$465.0M5.5%$21.5M$0.17
Q3 FY2024$489.6M3.3%$44.3M$0.37

Latest 8 reported quarters, from company XBRL filings on SEC EDGAR.

Company facts

ExchangeNYSE
SectorHealthcare
SIC industryServices-Specialty Outpatient Facilities, NEC
Latest annual periodFY2025 (ended December 31, 2025)
Latest reported quarterQ2 FY2026 (ended June 30, 2026)
Oldest indexed filing2024
SEC CIK2014596

Selected SEC filings

10-K2026-02-26
View on EDGAR →
10-Q2026-08-06
View on EDGAR →
10-Q2026-05-07
View on EDGAR →
8-K2026-08-27
View on EDGAR →
8-K2026-08-06
View on EDGAR →
8-K2026-07-10
View on EDGAR →
8-K2026-05-07
View on EDGAR →

Largest Healthcare peers

All Healthcare companies →

Monitor CON

Get an alert when Concentra Group Holdings Parent files something material, see which superinvestors own it, and ask its filings a question with cited answers.

Monitor CON free

Includes one free filing-grounded research answer. Or check your whole portfolio, no account needed.

Data sourced from SEC EDGAR. Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only. Not investment advice.